ArticleFrontiers in medicine2023

Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes.

Alexander Egeberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.